<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03442855</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1417</org_study_id>
    <nct_id>NCT03442855</nct_id>
  </id_info>
  <brief_title>Non-Interventional, Multicenter Bicontact® E PMCF Study</brief_title>
  <official_title>Non-Interventional, Multicenter Bicontact® E PMCF Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aesculap AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective observational (non-interventional) cohort study, multi-centric in 5 study Centers
      in Japan to collect short term clinical and radiological results of the cementless Bicontact®
      E stem in a standard patient population used in routine clinical practice
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Results</measure>
    <time_frame>1 year</time_frame>
    <description>Hip Score of the Japanese Orthopaedic Association (JOA): three categories—movement, mental, and pain—each comprising 7 items, for a total of 21 items to be used as evaluation criteria for hip-joint function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>1 year</time_frame>
    <description>Pain as measured with the Visual Analog Scale (VAS): Visual analog scale [VAS] is a measure of pain intensity. It is a continuous scale comprised of a horizontal analog scale of 100 mm length. It is anchored by two verbal descriptors, one for each symptom extreme [no pain - worst imaginable pain].</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>X-Ray evaluation</measure>
    <time_frame>1 year</time_frame>
    <description>Radiological results (osteointegration, migration)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(Serious) Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>Complications: Adverse Events (AE) / Serious Adverse Events (SAE)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Degenerative Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Femoral Neck Fractures</condition>
  <condition>Femoral Head Necrosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients receiving primary THA:

        Acute disorders of the hip that cannot be treated by other therapies:

          -  Degenerative osteoarthritis

          -  Rheumatic arthritis

          -  Joint fractures

          -  Femoral head necrosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for Bicontact E prosthesis THA

          -  Patients ≥ 18 years

          -  Patient not pregnant

          -  Written informed consent

        Exclusion Criteria:

        - Patients receiving a bipolar implantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne-Katrin Wacker</last_name>
    <phone>+49-7461-95-1509</phone>
    <email>anne_katrin.wacker@bbraun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kazuyuki Kuroda</last_name>
    <phone>0081338142539</phone>
    <email>kazuyuki.kuroda@bbraun.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Funabashi Orthopedic Hospital</name>
      <address>
        <city>Funabashi</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Niigata Bandai Hospital</name>
      <address>
        <city>Niigata</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Niigata Rinko Hospital</name>
      <address>
        <city>Niigata</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Niigata Univ. Medical &amp; Dental Hospital</name>
      <address>
        <city>Niigata</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dai Miyasaka, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saiseikai Niigata Second Hospital</name>
      <address>
        <city>Niigata</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2018</study_first_submitted>
  <study_first_submitted_qc>February 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthroplasty, Replacement, Hip</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Femoral Neck Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

